Format

Send to

Choose Destination
Ann Oncol. 2018 Jan 1;29(1):281-282. doi: 10.1093/annonc/mdx543.

Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.

Author information

1
Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
2
Klinik St. Anna, Luzern, Switzerland.
3
Breast Cancer Program, Istituto Europeo di Oncologia, Milan, Italy.
4
Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
5
German Breast Group, Neu-Isenburg, Germany.
6
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
7
Institut Jules Bordet, Bruxelles, Belgium.
8
Tumor and Breast Center ZeTuP, St Gallen, Switzerland.
9
Breast Center, Kantonsspital St. Gallen, St Gallen, Switzerland.
10
Institut de Cancérologie Gustave Roussy, Villejuif, France.
11
Memorial Sloan Kettering Cancer Center, New York, USA.
12
Karolinska Institute and University Hospital, Stockholm, Sweden.
13
University of Bordeaux, Bordeaux, France.
14
Universitäts-Frauenklinik Tübingen, Tübingen, Germany.
15
Champalimaud Cancer Centre, Lisbon, Portugal.
16
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.
17
Hospital Universitario 12 de Octubre, Madrid, Spain.
18
Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
19
Institut für Pathologie, Charité Universitätsmedizin Berlin, Berlin, Germany.
20
Azienda Usl Toscana Centro, Prato, Italy.
21
Rigshospitalet, Copenhagen, Denmark.
22
Peter McCallum Cancer Centre, Melbourne, Australia.
23
Marmara University School of Medicine, Istanbul, Turkey.
24
University of Toronto, Mount Sinai Hospital, Toronto, Canada.
25
University of Munich, München, Germany.
26
Comprehensive Cancer Center, University of Michigan, Ann-Arbor, USA.
27
National Taiwan University Hospital, Taipei, Taiwan.
28
University of Ulm, Ulm, Germany.
29
The National Cancer Institute, Cairo University, Cairo, Egypt.
30
Medical University of Gdansk, Gdansk, Poland.
31
Hospital Affiliated to Military Medical Science, Beijing, China.
32
Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrensky University Hospital, Gothenburg, Sweden.
33
Baylor College of Medicine, Houston, USA.
34
Institute of Oncology Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.
35
University of Toronto, Sunnybrook Odette Cancer Center, Toronto, Canada.
36
National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea.
37
Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
38
LKH Salzburg, Paracelsus Medical University Clinics, Salzburg, Austria.
39
N.N.Petrov Research Institute of Oncology, St. Petersburg, Russian Federation.
40
Fudan University Cancer Hospital, Shanghai, China.
41
The Royal Marsden, Sutton, Surrey, UK.
42
Graduate School of Medicine Kyoto University, Sakyo-ku Kyoto City, Japan.
43
Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK.
44
University of Milan, Milan, Italy.
45
Istituto Europeo di Oncologia, Milan, Italy.
46
Hamamatsu Oncology Center, Hamamatsu, Japan.
47
McMaster University, Hamilton, Canada.
48
National Cancer Center, Chaoyang District, Beijing, China.
PMID:
29045519
PMCID:
PMC6246427
DOI:
10.1093/annonc/mdx543
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center